Optimization of treatment options through a multidisciplinary approach for advanced hormone refractory prostate carcinoma
Dogliotti, L.; Mosca, A.
Tumori 93(2) Suppl: 17-23
2007
ISSN/ISBN: 0300-8916 PMID: 17557584 Document Number: 613348
Document emailed within 1 workday
Related Documents
Crawford, E.D.; Daneshgari, F.; Majeski, S.A. 1992: Etoposide in the treatment of hormone-refractory advanced carcinoma of the prostate Seminars in Oncology 19(6 Suppl 14: 53-57Hsieh, T-Chen.; Lu, X.; Guo, J.; Xiong, W.; Kunicki, J.; Darzynkiewicz, Z.; Wu, J.M. 2002: Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies International Journal of Oncology 20(4): 681-689
Dexeus, F.; Logothetis, C.J.; Samuels, M.L.; Hossan, E.; von Eschenbach, A.C. 1985: Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer Cancer Treatment Reports 69(7-8): 885-886
Colombel, M.; Davin, J.-L.; Filleul, A.; Rousseau, C. 2004: Diagnosis and management of advanced hormone-refractory prostate cancer: results of a practice survey on 301 French urologists Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(2): 182-188
Swanson, G.P. 2007: Treatment options in locally advanced prostate cancer Minerva Urologica e Nefrologica 59(1): 27-42
Arena, F. 2008: Dutasteride in the treatment of hormone refractory prostate cancer Minerva Urologica e Nefrologica 60(2): 71-76
Levine, L.A.; Harper, P.N. 1991: Extended inpatient treatment of a refractory heroin addict: a multidisciplinary approach to patients with a dual diagnosis Bulletin of the Menninger Clinic 55(3): 384-393
Ross, R.W.; Kantoff, P.W. 2007: Hormone-refractory prostate cancer: choosing the appropriate treatment option Oncology 21(2): 185-193; Discussion 194: 199-200
Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48
Kudo, H.; Seyama, Y.; Kanomata, H.; Takahashi, M.; Chang, T.; Matsuoka, Y.; Machida, T.; Furumoto, Y.; Warabi, M.; Tanizawa, T.; Wada, I.; Maeshiro, T.; Miyamoto, S.; Umekita, N. 2019: A Case of Resection of Advanced Pancreatic Adenosquamous Carcinoma in which Multidisciplinary Treatment Was Effective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(1): 178-180
Beerlage, H.P.; Thüroff, S.; Madersbacher, S.; Zlotta, A.R.; Aus, G.; de Reijke, T.M.; de la Rosette, J.J. 2000: Current status of minimally invasive treatment options for localized prostate carcinoma European Urology 37(1): 2-13
Mulders, P.F. 1999: Treatment of advanced prostate cancer: the vaccine approach Scandinavian Journal of Urology and Nephrology. Supplementum 203: 41-43
Shinmura, K.; Kaiho, T.; Yanagisawa, S.; Okamoto, R.; Nishimura, M.; Kobayashi, S.; Okaniwa, A.; Tsuchiya, S.; Shimizu, W. 2013: A case of effective multidisciplinary treatment for advanced gallbladder carcinoma with distant lymph node metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1750-1752
Goldenberg, G.; Hamid, O. 2013: Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease Journal of Drugs in Dermatology: Jdd 12(12): 1369-1378
Steyn, J.; Blair, D.W.; Morales, A. 1973: Treatment of advanced carcinoma of the prostate by yttrium-90 ablation South African Medical Journal 47(5): 179-180
Koyama, H.; Iesato, A.; Fukushima, Y.; Okada, T.; Watanabe, T.; Harada, M.; Ito, T.; Maeno, K.; Mochizuki, Y.; Ito, K.; Amano, J. 2011: A retrospective study of high-dose toremifene treatment for patients with aromatase inhibitor refractory advanced or metastatic hormone receptor-positive breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(7): 1123-1126
Kumar, N.; Vasudeva, P.; Kumar, A.; Singh, H.; Sinha, A. 2016: A prospective comparative study of channel photoselective vaporization of the prostate vs. channel transurethral resection of the prostate in patients with advanced prostate carcinoma Minerva Urologica e Nefrologica 68(4): 330-336
Kumar, N.; Vasudeva, P.; Kumar, A.; Singh, H.; Sinha, A. 2015: A prospective comparative study of channel photoselective vaporization of prostate vs. channel transurethral resection of prostate in patients with advanced carcinoma prostate Minerva Urologica e Nefrologica 2015
Roth, B.J. 1996: New therapeutic agents for hormone-refractory prostate cancer Seminars in Oncology 23(6 Suppl 14: 49-55
Wilkes, G.M. 2010: Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancer Oncology 24(10 Suppl): 46-48